A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Madelon Q. Wentink; Henk J. Broxterman; Siu W. Lam; Epie Boven; Maudy Walraven; Arjan W. Griffioen; Roberto Pili; Hans J. van der Vliet; Tanja D. de Gruijl; Henk M. W. Verheul

doi:10.1038/bjc.2016.275

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Madelon Q. Wentink
, Henk J. Broxterman
, Siu W. Lam
, Epie Boven
, Maudy Walraven
, Arjan W. Griffioen
, Roberto Pili
, Hans J. van der Vliet
, Tanja D. de Gruijl
, Henk M. W. Verheul

Research output: Contribution to journal › Article › Academic › peer-review

20 Downloads (Pure)

Original language	English
Pages (from-to)	940-948
Journal	British journal of cancer
Volume	115
Issue number	8
DOIs	https://doi.org/10.1038/bjc.2016.275
Publication status	Published - 11 Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

bioassay
VEGF
bevacizumab
proliferation assay
angiogenesis
antibody

Access to Document

10.1038/bjc.2016.275

A-functional-bioassay-to-determine-the-activity-of-anti-vegf-antibody-therapy-in-blood-of-patients-with-cancer.pdfFinal published version, 581 KBLicence: Taverne

Cite this

@article{9ded1ed3f7ba4d5bb69e715f8a976fd3,

title = "A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer",

keywords = "bioassay, VEGF, bevacizumab, proliferation assay, angiogenesis, antibody",

author = "Wentink, \{Madelon Q.\} and Broxterman, \{Henk J.\} and Lam, \{Siu W.\} and Epie Boven and Maudy Walraven and Griffioen, \{Arjan W.\} and Roberto Pili and \{van der Vliet\}, \{Hans J.\} and \{de Gruijl\}, \{Tanja D.\} and Verheul, \{Henk M. W.\}",

year = "2016",

month = oct,

day = "11",

doi = "10.1038/bjc.2016.275",

language = "English",

volume = "115",

pages = "940--948",

journal = "British journal of cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

AU - Wentink, Madelon Q.

AU - Broxterman, Henk J.

AU - Lam, Siu W.

AU - Boven, Epie

AU - Walraven, Maudy

AU - Griffioen, Arjan W.

AU - Pili, Roberto

AU - van der Vliet, Hans J.

AU - de Gruijl, Tanja D.

AU - Verheul, Henk M. W.

PY - 2016/10/11

Y1 - 2016/10/11

KW - bioassay

KW - VEGF

KW - bevacizumab

KW - proliferation assay

KW - angiogenesis

KW - antibody

U2 - 10.1038/bjc.2016.275

DO - 10.1038/bjc.2016.275

M3 - Article

C2 - 27575850

SN - 0007-0920

VL - 115

SP - 940

EP - 948

JO - British journal of cancer

JF - British journal of cancer

IS - 8

ER -